The first human genome sequencing took 13 years and cost $3 billion. It can now be done in a matter of days, but drawing meaningful conclusions from millions of points of data is cumbersome. However, ...
GeneDx Holdings (WGS) is poised for growth with strong Q2 results and SaaS transition. Read here for an investment analysis.
Hosted on MSN
New software promises to make precision genome editing with CRISPR accessible to more researchers
A Ph.D. student in biomolecular engineering at the University of California, Santa Cruz, has built a software program designed to facilitate the kind of precision genome editing involved in the ...
Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the H.C. Wainwright @ Home Event on Wednesday, ...
The presence or absence of remaining foreign DNA from the crossbred progeny of the genome-edited crop and the original crop cultivar can be determined by GenEditScan, based on the k-mer method.
The Company also offers an industry-leading, platform-agnostic genome analysis software solution, and nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) ...
Detailed price information for Bionano Genomics Inc (BNGO-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback